Weight loss

GIP/GLP-1 · Eli Lilly

Zepbound (tirzepatide)

Dual GIP/GLP-1 receptor agonist. The strongest weight-loss results in head-to-head trials with semaglutide. Once-weekly injection.

FDA-approved for

  • Chronic weight management
  • Obstructive sleep apnea (adults with obesity)

Cash reference: $349–$499 / month via LillyDirect

Why Ondoc for Zepbound

  • Insurance-first pricing — not a flat self-pay subscription
  • Compatible with LillyDirect self-pay if insurance declines
  • Dose titration managed by a licensed provider

Common questions about Zepbound

Can I use insurance for weight management with Ondoc?

Ondoc accepts Medicare and supported commercial insurance for clinical care; coverage for your weight-management visit is verified for your individual plan and service. General weight-management visits are $50 self-pay; the existing Qsymia evaluation is $100. Medication coverage depends on your plan.

Does Ondoc prescribe Wegovy, Zepbound or other GLP-1s?

Ondoc treats weight management, and GLP-1 medications such as Wegovy and Zepbound are among the options. Your Ondoc clinician decides what fits you.

Do I need a membership or subscription?

No. You can book a one-time visit. A membership is optional.

How do I start?

Pick insurance or self-pay, choose an available appointment time, and book.

Are compounded GLP-1s an option?

Ondoc prescribes FDA-approved GLP-1 medications and does not route these drugs to compounding pharmacies.